Literature DB >> 17907767

Appropriate calibration curve fitting in ligand binding assays.

John W A Findlay1, Robert F Dillard.   

Abstract

Calibration curves for ligand binding assays are generally characterized by a nonlinear relationship between the mean response and the analyte concentration. Typically, the response exhibits a sigmoidal relationship with concentration. The currently accepted reference model for these calibration curves is the 4-parameter logistic (4-PL) model, which optimizes accuracy and precision over the maximum usable calibration range. Incorporation of weighting into the model requires additional effort but generally results in improved calibration curve performance. For calibration curves with some asymmetry, introduction of a fifth parameter (5-PL) may further improve the goodness of fit of the experimental data to the algorithm. Alternative models should be used with caution and with knowledge of the accuracy and precision performance of the model across the entire calibration range, but particularly at upper and lower analyte concentration areas, where the 4- and 5-PL algorithms generally outperform alternative models. Several assay design parameters, such as placement of calibrator concentrations across the selected range and assay layout on multiwell plates, should be considered, to enable optimal application of the 4- or 5-PL model. The fit of the experimental data to the model should be evaluated by assessment of agreement of nominal and model-predicted data for calibrators.

Mesh:

Substances:

Year:  2007        PMID: 17907767      PMCID: PMC2751416          DOI: 10.1208/aapsj0902029

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  12 in total

1.  Bioanalytical method validation--a revisit with a decade of progress.

Authors:  V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.

Authors:  J W Findlay; W C Smith; J W Lee; G D Nordblom; I Das; B S DeSilva; M N Khan; R R Bowsher
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

3.  Workshop on bioanalytical methods validation for macromolecules: summary report.

Authors:  K J Miller; R R Bowsher; A Celniker; J Gibbons; S Gupta; J W Lee; S J Swanson; W C Smith; R S Weiner
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

4.  Statistical analysis of radioligand assay data.

Authors:  D Rodbard; G R Frazier
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

5.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

6.  The five-parameter logistic: a characterization and comparison with the four-parameter logistic.

Authors:  Paul G Gottschalk; John R Dunn
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

7.  Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Authors:  C T Viswanathan; Surendra Bansal; Brian Booth; Anthony J DeStefano; Mark J Rose; Jeffrey Sailstad; Vinod P Shah; Jerome P Skelly; Patrick G Swann; Russell Weiner
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

Review 8.  Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications.

Authors:  W C Smith; G S Sittampalam
Journal:  J Biopharm Stat       Date:  1998-11       Impact factor: 1.051

9.  Data-reduction methods for immunoradiometric assays of thyrotropin compared.

Authors:  M C Haven; P J Orsulak; L L Arnold; G Crowley
Journal:  Clin Chem       Date:  1987-07       Impact factor: 8.327

10.  Guidelines for immunoassay data processing.

Authors:  R A Dudley; P Edwards; R P Ekins; D J Finney; I G McKenzie; G M Raab; D Rodbard; R P Rodgers
Journal:  Clin Chem       Date:  1985-08       Impact factor: 8.327

View more
  71 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

2.  Functional assignment of YvgO, a novel set of purified and chemically characterized proteinaceous antifungal variants produced by Bacillus thuringiensis SF361.

Authors:  David C Manns; John J Churey; Randy W Worobo
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

3.  Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team.

Authors:  Marian Kelley; Christopher Beaver; Lauren F Stevenson; Ross Bamford; Paula Gegwich; Yamamoto Katsuhiko; Dongbei Li; Samantha Little; Arumugam Muruganandam; Daniela Stoellner; Ravi Kumar Trivedi
Journal:  AAPS J       Date:  2014-01-07       Impact factor: 4.009

4.  Salivary C-reactive protein among at-risk adolescents: A methods investigation of out of range immunoassay data.

Authors:  E R Landau; J Trinder; J G Simmons; M Raniti; M Blake; J M Waloszek; L Blake; O Schwartz; G Murray; N B Allen; M L Byrne
Journal:  Psychoneuroendocrinology       Date:  2018-09-08       Impact factor: 4.905

5.  ELIME (enzyme linked immuno magnetic electrochemical) method for mycotoxin detection.

Authors:  Daniela Romanazzo; Francesco Ricci; Silvia Vesco; Silvia Piermarini; Giulia Volpe; Danila Moscone; Giuseppe Palleschi
Journal:  J Vis Exp       Date:  2009-10-23       Impact factor: 1.355

6.  Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats.

Authors:  Leonid Kagan; Michael R Turner; Sathy V Balu-Iyer; Donald E Mager
Journal:  Pharm Res       Date:  2011-09-02       Impact factor: 4.200

7.  Multiplexed protein analysis using encoded antibody-conjugated microbeads.

Authors:  Nora Theilacker; Eric E Roller; Kristopher D Barbee; Matthias Franzreb; Xiaohua Huang
Journal:  J R Soc Interface       Date:  2011-01-19       Impact factor: 4.118

8.  Protein signaling networks from single cell fluctuations and information theory profiling.

Authors:  Young Shik Shin; F Remacle; Rong Fan; Kiwook Hwang; Wei Wei; Habib Ahmad; R D Levine; James R Heath
Journal:  Biophys J       Date:  2011-05-18       Impact factor: 4.033

9.  Molecular basis for the action of the collagen-specific chaperone Hsp47/SERPINH1 and its structure-specific client recognition.

Authors:  Christine Widmer; Jan M Gebauer; Elena Brunstein; Sabrina Rosenbaum; Frank Zaucke; Cord Drögemüller; Tosso Leeb; Ulrich Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

10.  Validated sandwich ELISA for the quantification of von Willebrand factor in rabbit plasma.

Authors:  Brendon W Smith; Jana Strakova; Jennifer L King; John W Erdman; William D O'Brien
Journal:  Biomark Insights       Date:  2010-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.